Three income stories are lining up ahead of the October earnings window, and each one has a different lever waiting to be pulled.

One rides the crude tape and a debt paydown that could unlock a bigger hike. Another leans on 5% Treasury yields to compound its investment book, while the third is a 69-year dividend raiser trading near 52-week lows.

While hyped air taxi giants burn hundreds of millions without delivering a single craft, a quiet rival just unlocked a new FAA rule change to bring a $99,000 flying car to the retail market.

They already have six working prototypes in the air and $27 million in orders before mainstream investors even notice.

Click here to read our full briefing on this under-the-radar stock before production officially takes off.

*Paid advertisement for AirCar's Regulation Crowdfunding offering. Not financial advice. Read the offering circular at invest.aircar.aero. All investments carry risk including loss of principal. Securities offered through DealMaker Securities LLC, member FINRA/SIPC. Pre-orders are non-binding reservations secured by deposits; they may be cancelled, may create refund obligations, and do not represent recognised revenue. The company reported $0 revenue for the 2024 and 2025 fiscal years. Competitor figures are manufacturer-published prices and targets. Specifications, pricing, certification timelines and order-book values are forward-looking company targets, remain subject to FAA certification, and are not guaranteed.

[ Publisher address block · Unsubscribe ]

Paramount Skydance Corporation (NASDAQ: PSKY) has settled lawsuits brought by California and 11 other states challenging its $110 billion acquisition of Warner Bros. Discovery, removing one of the biggest remaining obstacles to closing the transaction.

The combination would unite Paramount Pictures, CBS, Paramount+, HBO Max, CNN, Warner Bros. and major entertainment franchises inside one company. Paramount expects more than $6 billion in eventual cost savings.

The Savings Come With Heavy Debt

Paramount expects technology integration, procurement, real estate and corporate efficiencies to generate more than $6 billion in synergies. The combined company could also carry roughly $79 billion in net debt.

That debt belongs in your transformation calculation. Cost savings and greater scale must produce enough cash flow to support both future investment and a much larger balance sheet.

The Settlement Also Shapes the New Company

Paramount committed to at least 30 theatrical releases annually, $1.5 billion of additional U.S. production spending over five years, and protections for CNN and CBS editorial independence.

Those commitments also tell you Paramount cannot pursue savings simply by shrinking everything it acquires. The long-term test is whether greater scale produces a stronger media business without weakening the assets that made Warner Bros. valuable.

PSKY currently trades at $10 and pays a dividend of $0.20 per share, a yield of 1.94%.

Amgen Inc. (NASDAQ: AMGN) said dazodalibep met its main goal in a Phase 3 study for Sjögren’s disease, producing a statistically significant and clinically meaningful reduction in disease activity after 48 weeks. Most adverse events were mild to moderate.

The commercial opportunity stands out because no FDA-approved medicines currently treat Sjögren’s disease. Amgen is therefore pursuing more than another entrant into an established treatment category.

A New Market Could Be Created

Sjögren’s affects moisture-producing glands and can also cause fatigue, chronic pain, nerve problems, and organ involvement. Reuters says the disease affects about 1% of the global population.

Approval of a therapy here would change how you frame the opportunity. Amgen would be competing to establish a new standard of care rather than simply taking share from an entrenched drug.

Horizon Could Deliver Another Growth Asset

Dazodalibep came into Amgen through its Horizon Therapeutics acquisition, giving the company another chance to extract long-term value from that deal beyond Horizon’s existing commercial drugs.

Detailed trial data and regulatory decisions still sit ahead, but by then you will be judging something larger than one positive study.

The question becomes whether Amgen can turn an acquired pipeline asset into the first major commercial treatment for an underserved disease.

AMGN currently trades at $411 and pays a dividend of $10.08 per share, a yield of 2.44%.

Only a tiny percentage of stocks meet the criteria for this report.

Analysts have released a new edition highlighting seven names selected using multiple indicators.

Recent picks have delivered notable short-term gains, though results can vary.

The latest report is now available for a limited time.

Download the free report today.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.

*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Blackstone Inc. (NYSE: BX) has returned with a higher offer for IDP Education, proposing about A$694.7 million, or roughly $494 million, for the Australian company. IDP rejected the A$2.50-per-share proposal, saying it still undervalues the business.

The timing is what makes the approach interesting. IDP’s revenue fell 23% in fiscal 2026, and statutory profit dropped 90% as tighter immigration and visa policies reduced international student flows.

Blackstone Is Buying Into Weakness

IDP co-owns IELTS and runs a global student-placement network that connects students with universities across major study destinations. Those assets have not disappeared just because volumes weakened.

The valuation looks different once you separate depressed current earnings from the global platform Blackstone is trying to acquire. A recovery in student mobility could drive far more activity through existing infrastructure.

A Second Bid Shows Real Interest

Blackstone first offered A$2.30 per share before increasing the proposal to A$2.50, a 56% premium to IDP’s September 8 closing price. IDP has rejected both approaches.

That persistence tells you Blackstone sees value beyond the current numbers. The next step is whether it raises the price again or decides the recovery potential no longer justifies paying more.

BX currently trades at $124 and pays a dividend of $4.74 per share, a yield of 3.81%.

Texas Instruments (TXN) raised its quarterly dividend 7% to $1.52 per share, extending the streak to 23 consecutive years, payable November 10.

McDonald's (MCD) lifted its quarterly payout 4% to $1.93, marking 50 straight years of increases and Dividend King status, payable December 15.

Philip Morris (PM) boosted its quarterly dividend 8.8% to $1.60 per share, annualized to $6.40.

JPMorgan Chase (JPM) hiked its quarterly dividend 10% to $1.65, payable October 31.

Lument Finance Trust (LFT) suspended its common stock dividend starting with the third-quarter payment that would have been paid in October.

Stellantis (STLA) is passing on its 2026 annual dividend after posting a full-year 2025 net loss and resetting its business plan around a leaner capital profile.

Crown Castle (CCI) is holding at the rebased $1.0625 quarterly rate following its earlier cut from $1.565.

A former Wall Street banker just flagged a quiet Federal Reserve docket that lays the groundwork for a mandatory digital dollar.

Over 1,400 banks are already connected to this new system, but a simple legal strategy lets investors move their cash completely outside central bank control.

Click here to see how to protect your wealth before this window closes for good.

*This content is for educational purposes only. The opinions expressed are from DM Intelligence LLC, doing business as Decentralized Masters, who are not licensed financial advisors or registered investment advisors. The reader acknowledges that DM Intelligence LLC is not responsible for any losses, direct or indirect, resulting from the use of this information, including errors, omissions, or inaccuracies.

*Results are not typical and will vary. Success with digital currencies requires time, effort, and involves substantial risk including total loss of investment. Past performance does not indicate future results. All investments are at your own risk.

Please click here if you would like to unsubscribe.